Annual Gross Profit
$42.90 M
+$3.93 M+10.09%
December 31, 2023
Summary
- As of March 6, 2025, OPRX annual gross profit is $42.90 million, with the most recent change of +$3.93 million (+10.09%) on December 31, 2023.
- During the last 3 years, OPRX annual gross profit has risen by +$18.79 million (+77.97%).
- OPRX annual gross profit is now at all-time high.
Performance
OPRX Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Gross Profit
$13.45 M
+$1.74 M+14.89%
September 30, 2024
Summary
- As of March 6, 2025, OPRX quarterly gross profit is $13.45 million, with the most recent change of +$1.74 million (+14.89%) on September 30, 2024.
- Over the past year, OPRX quarterly gross profit has increased by +$3.65 million (+37.21%).
- OPRX quarterly gross profit is now -24.63% below its all-time high of $17.84 million, reached on December 31, 2023.
Performance
OPRX Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Gross Profit
$55.20 M
+$3.65 M+7.07%
September 30, 2024
Summary
- As of March 6, 2025, OPRX TTM gross profit is $55.20 million, with the most recent change of +$3.65 million (+7.07%) on September 30, 2024.
- Over the past year, OPRX TTM gross profit has increased by +$17.68 million (+47.14%).
- OPRX TTM gross profit is now at all-time high.
Performance
OPRX TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Gross Profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
OPRX Gross Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.1% | +37.2% | +47.1% |
| 3 y3 years | +78.0% | +8.5% | +54.9% |
| 5 y5 years | +251.4% | +200.6% | +257.5% |
OPRX Gross Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +20.4% | -24.6% | +80.9% | at high | +54.9% |
| 5 y | 5-year | at high | +177.9% | -24.6% | +209.6% | at high | +257.5% |
| alltime | all time | at high | >+9999.0% | -24.6% | >+9999.0% | at high | >+9999.0% |
OptimizeRx Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $13.45 M(+14.9%) | $55.20 M(+7.1%) |
| Jun 2024 | - | $11.70 M(-4.1%) | $51.55 M(+8.1%) |
| Mar 2024 | - | $12.20 M(-31.6%) | $47.67 M(+11.1%) |
| Dec 2023 | $42.90 M(+10.1%) | $17.84 M(+82.0%) | $42.90 M(+14.4%) |
| Sep 2023 | - | $9.80 M(+25.2%) | $37.51 M(+1.0%) |
| Jun 2023 | - | $7.83 M(+5.3%) | $37.13 M(-3.0%) |
| Mar 2023 | - | $7.43 M(-40.3%) | $38.30 M(-1.7%) |
| Dec 2022 | $38.97 M(+9.3%) | $12.45 M(+32.2%) | $38.97 M(+0.2%) |
| Sep 2022 | - | $9.42 M(+4.8%) | $38.90 M(+0.9%) |
| Jun 2022 | - | $8.99 M(+11.0%) | $38.56 M(+2.5%) |
| Mar 2022 | - | $8.10 M(-34.6%) | $37.62 M(+5.5%) |
| Dec 2021 | $35.64 M(+47.8%) | $12.39 M(+36.5%) | $35.64 M(+11.9%) |
| Sep 2021 | - | $9.08 M(+12.8%) | $31.85 M(+10.6%) |
| Jun 2021 | - | $8.04 M(+31.4%) | $28.79 M(+11.2%) |
| Mar 2021 | - | $6.12 M(-28.8%) | $25.89 M(+7.4%) |
| Dec 2020 | $24.11 M(+56.1%) | $8.60 M(+43.1%) | $24.11 M(+20.7%) |
| Sep 2020 | - | $6.01 M(+16.9%) | $19.97 M(+17.6%) |
| Jun 2020 | - | $5.14 M(+18.5%) | $16.98 M(+5.1%) |
| Mar 2020 | - | $4.34 M(-2.9%) | $16.16 M(+4.6%) |
| Dec 2019 | $15.44 M(+26.5%) | $4.47 M(+48.0%) | $15.44 M(+2.5%) |
| Sep 2019 | - | $3.02 M(-30.0%) | $15.06 M(-0.8%) |
| Jun 2019 | - | $4.32 M(+19.1%) | $15.18 M(+10.6%) |
| Mar 2019 | - | $3.63 M(-11.4%) | $13.73 M(+12.5%) |
| Dec 2018 | $12.21 M(+105.1%) | $4.09 M(+30.1%) | $12.21 M(+14.8%) |
| Sep 2018 | - | $3.15 M(+9.9%) | $10.64 M(+19.7%) |
| Jun 2018 | - | $2.86 M(+36.1%) | $8.89 M(+22.0%) |
| Mar 2018 | - | $2.10 M(-16.6%) | $7.29 M(+22.4%) |
| Dec 2017 | $5.95 M(+37.2%) | $2.52 M(+80.4%) | $5.95 M(+22.7%) |
| Sep 2017 | - | $1.40 M(+11.0%) | $4.85 M(+7.4%) |
| Jun 2017 | - | $1.26 M(+63.6%) | $4.51 M(+6.4%) |
| Mar 2017 | - | $770.30 K(-45.8%) | $4.24 M(-2.2%) |
| Dec 2016 | $4.34 M | $1.42 M(+33.6%) | $4.34 M(+8.5%) |
| Sep 2016 | - | $1.06 M(+7.3%) | $4.00 M(+2.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2016 | - | $990.50 K(+14.3%) | $3.90 M(+4.5%) |
| Mar 2016 | - | $866.70 K(-19.8%) | $3.73 M(+3.8%) |
| Dec 2015 | $3.60 M(+9.7%) | $1.08 M(+12.3%) | $3.60 M(+2.4%) |
| Sep 2015 | - | $963.00 K(+17.0%) | $3.51 M(+3.0%) |
| Jun 2015 | - | $823.10 K(+12.6%) | $3.41 M(+3.8%) |
| Mar 2015 | - | $731.10 K(-26.6%) | $3.28 M(+0.1%) |
| Dec 2014 | $3.28 M(+16.4%) | $995.70 K(+15.6%) | $3.28 M(+1.8%) |
| Sep 2014 | - | $861.10 K(+23.6%) | $3.22 M(+0.5%) |
| Jun 2014 | - | $696.70 K(-4.3%) | $3.20 M(+1.4%) |
| Mar 2014 | - | $728.00 K(-22.2%) | $3.16 M(+7.4%) |
| Dec 2013 | $2.82 M(+50.4%) | $936.10 K(+10.9%) | $2.94 M(+12.7%) |
| Sep 2013 | - | $843.90 K(+29.3%) | $2.61 M(+18.7%) |
| Jun 2013 | - | $652.60 K(+28.1%) | $2.20 M(+7.1%) |
| Mar 2013 | - | $509.50 K(-15.7%) | $2.05 M(+9.6%) |
| Dec 2012 | $1.87 M(+2535.3%) | $604.60 K(+39.8%) | $1.87 M(+47.6%) |
| Sep 2012 | - | $432.50 K(-14.7%) | $1.27 M(+23.4%) |
| Jun 2012 | - | $507.30 K(+54.0%) | $1.03 M(+42.6%) |
| Mar 2012 | - | $329.40 K(+71.9%) | $721.20 K(-9.6%) |
| Sep 2011 | - | $191.60 K(-4.3%) | $798.00 K(+23.3%) |
| Jun 2011 | - | $200.20 K(-49.2%) | $647.10 K(+39.6%) |
| Mar 2011 | - | $393.80 K(+3075.8%) | $463.60 K(+552.0%) |
| Dec 2010 | $71.10 K(+166.3%) | $12.40 K(-69.5%) | $71.10 K(-3.7%) |
| Sep 2010 | - | $40.70 K(+143.7%) | $73.80 K(+84.5%) |
| Jun 2010 | - | $16.70 K(+1184.6%) | $40.00 K(+49.8%) |
| Mar 2010 | - | $1300.00(-91.4%) | $26.70 K(0.0%) |
| Dec 2009 | $26.70 K(-68.1%) | $15.10 K(+118.8%) | $26.70 K(-1.1%) |
| Sep 2009 | - | $6900.00(+102.9%) | $27.00 K(+27.4%) |
| Jun 2009 | - | $3400.00(+161.5%) | $21.20 K(-38.6%) |
| Mar 2009 | - | $1300.00(-91.6%) | $34.50 K(-58.8%) |
| Dec 2008 | $83.70 K(-16.6%) | $15.40 K(+1300.0%) | $83.70 K(+22.5%) |
| Sep 2008 | - | $1100.00(-93.4%) | $68.30 K(+1.6%) |
| Jun 2008 | - | $16.70 K(-66.9%) | $67.20 K(+33.1%) |
| Mar 2008 | - | $50.50 K | $50.50 K |
| Dec 2007 | $100.30 K | - | - |
FAQ
- What is OptimizeRx annual gross profit?
- What is the all time high annual gross profit for OptimizeRx?
- What is OptimizeRx annual gross profit year-on-year change?
- What is OptimizeRx quarterly gross profit?
- What is the all time high quarterly gross profit for OptimizeRx?
- What is OptimizeRx quarterly gross profit year-on-year change?
- What is OptimizeRx TTM gross profit?
- What is the all time high TTM gross profit for OptimizeRx?
- What is OptimizeRx TTM gross profit year-on-year change?
What is OptimizeRx annual gross profit?
The current annual gross profit of OPRX is $42.90 M
What is the all time high annual gross profit for OptimizeRx?
OptimizeRx all-time high annual gross profit is $42.90 M
What is OptimizeRx annual gross profit year-on-year change?
Over the past year, OPRX annual gross profit has changed by +$3.93 M (+10.09%)
What is OptimizeRx quarterly gross profit?
The current quarterly gross profit of OPRX is $13.45 M
What is the all time high quarterly gross profit for OptimizeRx?
OptimizeRx all-time high quarterly gross profit is $17.84 M
What is OptimizeRx quarterly gross profit year-on-year change?
Over the past year, OPRX quarterly gross profit has changed by +$3.65 M (+37.21%)
What is OptimizeRx TTM gross profit?
The current TTM gross profit of OPRX is $55.20 M
What is the all time high TTM gross profit for OptimizeRx?
OptimizeRx all-time high TTM gross profit is $55.20 M
What is OptimizeRx TTM gross profit year-on-year change?
Over the past year, OPRX TTM gross profit has changed by +$17.68 M (+47.14%)